SUS (Single Use System) for Biopharma Process Market - Global Growth, Trends and Forecast (2022 - 2027) By Types, By Application, By Regions and By Key Players: Tofflon, Truking, Duoning Biotechnology, Lepure China

Registering a CAGR of 20.9% over the forecast period, the market value of SUS (Single Use System) for Biopharma Process is expected to reach US$ 21.5 billion in the year 2027.

SUS (Single Use System) for Biopharma Process Market Overview

Single-use Systems (SUS) are seen as an economically feasible way for many end-users to achieve optimum process efficiency and productivity. As a result, SUS equipment is widely used throughout the biomanufacturing process, especially in pre-commercial biopharmaceutical production. This has opened up chances for product suppliers in the industry.

In response to the novel coronavirus pandemic, many biopharmaceutical companies have been swiftly developing vaccines. If these development initiatives make it through the trial stages, single-use equipment and systems will be used to support clinical and commercial manufacturing platforms. Because the majority of the leading COVID-19 vaccine programs rely on innovative techniques like mRNA, DNA vaccines, and vectors, these platforms are generally based on single-use systems. Single-use systems are more adaptable and may be implemented more rapidly at a lesser cost than typical stainless-steel equipment, which requires considerable upfront investments and offers no guarantee of future longevity.

The report aspects discussed the profile of the top manufacturers of the global SUS (Single Use System) for Biopharma Process market. These aspects include financial status of major companies, trending advancements and entire market scenario. Growth of the report have examined SUS (Single Use System) for Biopharma Process Market production, demand and growth potential, geographic analysis, as well as current market developments in various regions and countries.

Industry News and Updates:

Danaher Completes Acquisition of The Biopharma Business of General Electric Life Sciences; Business Will Be Called Cytiva

March 31, 2020-- Danaher Corporation (NYSE: DHR) ("Danaher") announced today the completion of its acquisition of the Biopharma business from General Electric Company's (NYSE: GE) Life Sciences division. As part of Danaher, the business will be called Cytiva and will be a standalone operating company within Danaher's Life Sciences segment.

Thermo Fisher Scientific to Further Expand Global Network of Single-Use Technology Manufacturing Sites

Sept. 8, 2021-- Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science,  announced plans to establish a manufacturing facility in Nashville dedicated to the production of single-use technologies (SUT) products. This investment is in addition to the previously announced expansion to address unprecedented demand in the bioprocessing market.  The facility will be one of the world's largest SUT manufacturing sites and will more than double the company's SUT manufacturing capacity in support of its biopharma customers. The first phase of construction will be operational by the second quarter of 2022.

What are the major Applications, Types and Regions for SUS (Single Use System) for Biopharma Process Market?

Market is segmented based on the type, applications, companies and regions.

By Type, it is segmented into

• Single Use Bioreactors Bags


• Filtration and Sampling Systems


• Others

By Application, it is segmented into

• Cell Therapy


• Vaccine Production


• MAB and Recombinant Proteins


• Others

SUS (Single Use System) for Biopharma Process Market Regional Analysis

Because of increased healthcare spending, technological advancements in bioprocessing, and the growing relevance of life science research, North America is the largest single-use bioprocessing market. The benefits of using single-use bioprocessing items include higher acceptance of disposable systems, increased energy efficiency, and a lower chance of product cross-contamination. Furthermore, automation, big data technologies, and artificial intelligence have been rapidly gaining popularity in the single-use system in North America. The increased economic activity of these contract manufacturers will significantly drive the growth of the single-use bioprocessing market in North America. Asia Pacific is characterized by growing production of biosimilars, cell therapy, vaccines, and various other types of biopharmaceutical products. Moreover, China is the second largest biopharmaceutical market just after the US. China’s economic policies to attract FDIs for setting up manufacturing plants for biopharmaceutical products is exponentially fostering the demand for single-use bioprocessing technology. Moreover, nations like India, Japan, and South Korea have been a leading player in the Asia Pacific region.

• North America
  
  
  
  
  • US
  
  
  • Canada
  
  
  
  


• Europe
  
  
  
  • Germany
  
  
  • France
  
  
  • UK
  
  
  • Italy
  
  
  • Spain
  
  
  • Rest of Europe
  
  
  
  


• Asia-Pacific
  
  
  
  • China
  
  
  • Japan
  
  
  • India
  
  
  • Australia
  
  
  • South Korea
  
  
  • Rest of Asia-Pacific
  
  
  
  


• Rest of the World
  
  
  
  • Middle East & Africa
  
  
  • Latin America
  
  
  
  

The SUS (Single Use System) for Biopharma Process Market describes the factors driving the global growth opportunities in upcoming years and highlights market channels. In addition, the report analyzes market size and share, trends, by geographic region, end-use type and segment. It focuses extensively on revealing a detailed regional analysis. The Global SUS (Single Use System) for Biopharma Process Market report also conducted a PESTEL analysis of the industry to study the main influencing factors and entry barriers of the industry.

What is our SUS (Single Use System) for Biopharma Process Market report scope?

Key Takeaways from this SUS (Single Use System) for Biopharma Process Report

• Evaluate SUS (Single Use System) for Biopharma Process market potential through analyzing growth rates (CAGR %), Volume (Units) and Value ($M) data given at country level - for product types, end use applications and by different industry verticals.


• Understand the different dynamics influencing the market - growth driving factors, specific challenges and hidden opportunities.


• Get in-depth insights on your competitor performance – revenue, shares, business strategies, financial benchmarking, product benchmarking, SWOT analysis and more.


• Analyze the sales and distribution channels across geographies to enhance top-line revenues.


• Understand the demanding supply chain with a deep dive on the value augmentation at each, in order to optimize value and bring efficiencies in your processes.


• Get a quick outlook on the SUS (Single Use System) for Biopharma Process market entropy - M&A's, deals, partnerships, product launches of all key players for the past 5 years.


• Evaluate the import-export statistics, supply-demand and competitive landscape for more than top 20 countries globally for the market.

Frequently Asked Questions

What is the study period of this market?

The SUS (Single Use System) for Biopharma Process Market is studied from 2017 - 2027.

What is the growth rate of SUS (Single Use System) for Biopharma Process Market?

The SUS (Single Use System) for Biopharma Process Market is growing at a CAGR of 20.9% over the next 5 years.

Who are the key players in SUS (Single Use System) for Biopharma Process Market?

Tofflon, Truking, Duoning Biotechnology, Lepure China, JYSS Bio-Engineering, AUSTAR, Lisure Science, Thermo Fisher Scientific Inc. (NYSE:TMO),  MERCK Kommanditgesellschaft auf Aktien (XETRA:MRK.DE), Danaher Corporation (NYSE:DHR)

What regions does this SUS (Single Use System) for Biopharma Process Market report covers?

North America (the United States, Canada, and Mexico)

Europe (Germany, France, UK, Russia, and Italy)

Asia-Pacific (China, Japan, Korea, India, and Southeast Asia)

South America (Brazil, Argentina, Colombia, etc.)

The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, and South Africa)

What are the significant types of SUS (Single Use System) for Biopharma Process Market?

Single Use Bioreactors Bags, Filtration and Sampling Systems, Others

What are the major end-use applications of SUS (Single Use System) for Biopharma Process Market?

Cell Therapy, Vaccine Production, MAB and Recombinant Proteins, Others

All our reports are custom made to your company needs to a certain extent, we do provide 5 free consulting hours along with purchase of each report, and this will allow you to request any additional data to customize the report as your needs.